Group One Trading
BEAM icon

Group One Trading’s Beam Therapeutics BEAM Stock Holding History

Group One Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.6K Sell
3,216
-5,736
-64% -$159K ﹤0.01% 4948
2025
Q4 		$248K Buy
+8,952
New +$228K ﹤0.01% 4182
2025
Q3 		– Sell
-39,323
Closed -$782K – 8404
2025
Q2 		$669K Buy
39,323
+38,133
+3,204% +$664K ﹤0.01% 3130
2025
Q1 		$23.2K Buy
+1,190
New +$31.2K ﹤0.01% 5717
2024
Q2 		– Sell
-2,453
Closed -$60.2K – 6723
2024
Q1 		$81K Buy
+2,453
New +$76.4K ﹤0.01% 4327
2023
Q4 		– Sell
-9,899
Closed -$246K – 7387
2023
Q3 		$238K Buy
9,899
+8,042
+433% +$216K ﹤0.01% 3653
2023
Q2 		$59.3K Sell
1,857
-18,476
-91% -$600K ﹤0.01% 5128
2023
Q1 		$623K Buy
20,333
+2,313
+13% +$91.3K ﹤0.01% 2554
2022
Q4 		$705K Buy
+18,020
New +$807K ﹤0.01% 2722
2022
Q2 		– Sell
-92,760
Closed -$3.69M – 7807
2022
Q1 		$5.32M Buy
+92,760
New +$6.08M 0.01% 1501
2021
Q4 		– Sell
-2,624
Closed -$225K – 8207
2021
Q3 		$228K Buy
+2,624
New +$264K ﹤0.01% 5032
2021
Q1 		– Sell
-3,998
Closed -$380K – 7569
2020
Q4 		$326K Buy
+3,998
New +$197K ﹤0.01% 3660

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Group One Trading's BEAM Position: Q1 2026 in Review

Group One Trading reduced its Beam Therapeutics (BEAM) stake by 64% in Q1 2026, selling an estimated $159K and leaving 3,216 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4948.

Group One Trading first reported a position in BEAM in Q4 2020 and has held it in 12 quarters since. The position peaked at $5.32M in Q1 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Group One Trading held 3,216 shares of Beam Therapeutics worth $76.6K as of Q1 2026.
  • Group One Trading sold 5,736 Beam Therapeutics shares in Q1 2026, an estimated $159K.
  • Beam Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4948 holding.
  • Group One Trading first reported a position in Beam Therapeutics in Q4 2020 and has held it in 12 quarters since.
  • Group One Trading's Beam Therapeutics position peaked at $5.32M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.